z-logo
open-access-imgOpen Access
Chromatin configuration of the human CD2 gene locus during T-cell development.
Author(s) -
David Wotton,
Brian Flanagan,
Michael John Owen
Publication year - 1989
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.86.11.4195
Subject(s) - chromatin , hypersensitive site , biology , dnase i hypersensitive site , gene , chia pet , deoxyribonuclease i , microbiology and biotechnology , gene expression , dna methylation , regulation of gene expression , regulatory sequence , locus control region , transcription factor , genetics , promoter , transcriptional regulation , chromatin remodeling , base sequence
To investigate the molecular basis for the tissue-specific expression of the human CD2 gene, its chromatin configuration was assessed by determining DNase I hypersensitivity and the degree of methylation during T-cell lineage commitment and development. Tissue-specific DNase I-hypersensitive sites were found within the 5' promoter region and a region 3' of the gene essential for gene expression. DNase I hypersensitivity of the 5' region correlated strictly with transcriptional activity, whereas hypersensitivity of the 3' region correlated with T-cell progenitor activity or lineage commitment but not necessarily with transcription. Hha I and Hpa II sites around the 5' and 3' regions were undermethylated in CD2-expressing T cells but were more extensively methylated in other cell types. These results define likely regulatory elements both upstream and downstream of the CD2 gene that control its tissue-specific expression. Further, they show that the 3' regulatory region adopts an open chromatin configuration prior to lineage commitment and during early stages of T-cell development before the CD2 gene is transcribed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here